115 related articles for article (PubMed ID: 6178881)
1. [Method of determining von Willebrand factor activity].
Papaian LP
Lab Delo; 1982; (5):275-8. PubMed ID: 6178881
[No Abstract] [Full Text] [Related]
2. [Quantitative determination of Willebrand factor activity in Willebrand's disease].
Buchvarova V; Samama M; Lecrubier C
Vutr Boles; 1976; 15(3):92-4. PubMed ID: 1086035
[TBL] [Abstract][Full Text] [Related]
3. [Methods of measurement of Willebrand activity on microtitration plates].
Sultan Y; Rossi J
Nouv Presse Med; 1977 Jan; 6(1):44-6. PubMed ID: 299940
[No Abstract] [Full Text] [Related]
4. [Von Willebrand disease--a variation with an aberrant multimeric structure].
Batlle Fonrodona J; López Fernández MF; Fernández Villamor A; López Berges C; Lasierra Cirujeda J; López Borrasca A
Sangre (Barc); 1985; 30(2):146-53. PubMed ID: 3925572
[No Abstract] [Full Text] [Related]
5. [Comparative study on two methods of quantitative assay for von Willebrand factor using a washed-platelet-system and a fixed-washed-platelet-system (author's transl)].
Kajikawa M; Taketomi Y; Ihara A; Nakagawa J; Fujimura K
Rinsho Ketsueki; 1976 Aug; 17(8):868-75. PubMed ID: 1088552
[No Abstract] [Full Text] [Related]
6. Assay of ristocetin cofactor: experience with a platelet counting technique.
Bird AR; Sacks R; Smith A
Med Lab Sci; 1984 Jan; 41(1):38-45. PubMed ID: 6609295
[No Abstract] [Full Text] [Related]
7. [Screening method of determining the activity of the Willebrand factor].
Smolianitskiĭ AIa; Iakunin GA
Lab Delo; 1983; (4):48-50. PubMed ID: 6191085
[No Abstract] [Full Text] [Related]
8. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
9. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
Shihong I; Morris D; Konkle BA
Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
[TBL] [Abstract][Full Text] [Related]
10. [Simple rapid test for assaying ristocetin cofactor].
Aznar JA; Borrego D; Martín G; Jorquera J; Jiménez C; García I; Marty ML
Sangre (Barc); 1982; 27(5):959-66. PubMed ID: 6984787
[No Abstract] [Full Text] [Related]
11. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
[TBL] [Abstract][Full Text] [Related]
12. On the significance of marginally low von Willebrand factor.
Onundarson PT; Gudmundsdottir BR; Marder VJ
Thromb Haemost; 2008 Dec; 100(6):1213-4. PubMed ID: 19132256
[No Abstract] [Full Text] [Related]
13. Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease.
Rosborough TK; Johnson GS; Benson RE; Swaim WR; Dodds WJ
J Lab Clin Med; 1980 Jul; 96(1):47-56. PubMed ID: 6967101
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases].
Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A
Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797
[No Abstract] [Full Text] [Related]
15. Letter: A method for assaying von Willebrand factor (ristocetin cofactor).
Macfarlane DE; Stibbe J; Kirby EP; Zucker MB; Grant RA; McPherson J
Thromb Diath Haemorrh; 1975 Sep; 34(1):306-8. PubMed ID: 1081281
[No Abstract] [Full Text] [Related]
16. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.
Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ
Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130
[TBL] [Abstract][Full Text] [Related]
17. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of a new automated method for von Willebrand factor antigen measurement: the STA-Liatest vWF].
Veyradier A; Fressinaud E; Sigaud M; Wolf M; Meyer D
Ann Biol Clin (Paris); 1999 May; 57(3):364-8. PubMed ID: 10377492
[No Abstract] [Full Text] [Related]
19. Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing.
Favaloro EJ; Soltani S; McDonald J
Am J Clin Pathol; 2004 Nov; 122(5):686-92. PubMed ID: 15491964
[TBL] [Abstract][Full Text] [Related]
20. [Hemostasis disorders with reduced activity of the von Willebrand factor in myeloproliferative syndromes].
Leupin L; Beck EA; Furlan M; Bucher U
Schweiz Med Wochenschr; 1983 May; 113(19):713-6. PubMed ID: 6603016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
